Rebecca Pavlos
Rebecca Pavlos
Verified email at
Cited by
Cited by
HLA and pharmacogenetics of drug hypersensitivity
R Pavlos, S Mallal, E Phillips
Pharmacogenomics 13 (11), 1285-1306, 2012
Cloning, sequencing, and functional characterization of the rat homologue of receptor activator of NF‐κB ligand
J Xu, JW Tan, L Huang, XH Gao, R Laird, D Liu, S Wysocki, MH Zheng
Journal of Bone and Mineral Research 15 (11), 2178-2186, 2000
Improving the effectiveness of penicillin allergy de-labeling
J Bourke, R Pavlos, I James, E Phillips
The Journal of Allergy and Clinical Immunology: In Practice 3 (3), 365-374. e1, 2015
SJS/TEN 2017: building multidisciplinary networks to drive science and translation
KD White, R Abe, M Ardern-Jones, T Beachkofsky, C Bouchard, ...
The Journal of Allergy and Clinical Immunology: In Practice 6 (1), 38-69, 2018
T cell–mediated hypersensitivity reactions to drugs
R Pavlos, S Mallal, D Ostrov, S Buus, I Metushi, B Peters, E Phillips
Annual review of medicine 66, 439, 2015
Fever, rash, and systemic symptoms: understanding the role of virus and HLA in severe cutaneous drug allergy
R Pavlos, S Mallal, D Ostrov, Y Pompeu, E Phillips
The Journal of Allergy and Clinical Immunology: In Practice 2 (1), 21-33, 2014
HLA-A* 32: 01 is strongly associated with vancomycin-induced drug reaction with eosinophilia and systemic symptoms
KC Konvinse, JA Trubiano, R Pavlos, I James, CM Shaffer, CA Bejan, ...
Journal of allergy and clinical immunology 144 (1), 183-192, 2019
HLAs: key regulators of T‐cell‐mediated drug hypersensitivity
AJ Redwood, RK Pavlos, KD White, EJ Phillips
Hla 91 (1), 3-16, 2018
Abacavir-reactive memory T cells are present in drug naive individuals
A Lucas, M Lucas, A Strhyn, NM Keane, E McKinnon, R Pavlos, ...
PloS one 10 (2), e0117160, 2015
A TNF-regulated recombinatorial macrophage immune receptor implicated in granuloma formation in tuberculosis
AW Beham, K Puellmann, R Laird, T Fuchs, R Streich, C Breysach, ...
PLoS pathogens 7 (11), e1002375, 2011
Associations between HLA-DRB1* 0102, HLA-B* 5801 and hepatotoxicity during initiation of Nevirapine-containing regimens in South Africa
E Phillips, JA Bartlett, I Sanne, MM Lederman, J Hinkle, F Rousseau, ...
Journal of acquired immune deficiency syndromes (1999) 62 (2), e55, 2013
HLA Class I restricted CD8+ and Class II restricted CD4+ T cells are implicated in the pathogenesis of nevirapine hypersensitivity
NM Keane, RK Pavlos, E McKinnon, A Lucas, C Rive, CC Blyth, D Dunn, ...
Aids 28 (13), 1891-1901, 2014
Pharmacogenomics of off‐target adverse drug reactions
SL Garon, RK Pavlos, KD White, NJ Brown, CA Stone Jr, EJ Phillips
British journal of clinical pharmacology 83 (9), 1896-1911, 2017
Individualization of antiretroviral therapy
R Pavlos, EJ Phillips
Pharmacogenomics and personalized medicine 5, 1, 2012
The combined utility of ex vivo IFN-γ release enzyme-linked immunospot assay and in vivo skin testing in patients with antibiotic-associated severe cutaneous adverse reactions
JA Trubiano, K Strautins, AJ Redwood, R Pavlos, KC Konvinse, AK Aung, ...
The Journal of Allergy and Clinical Immunology: In Practice 6 (4), 1287-1296. e1, 2018
Shared peptide binding of HLA Class I and II alleles associate with cutaneous nevirapine hypersensitivity and identify novel risk alleles
R Pavlos, EJ McKinnon, DA Ostrov, B Peters, S Buus, D Koelle, A Chopra, ...
Scientific reports 7 (1), 1-12, 2017
High‐avidity, high‐IFNγ‐producing CD8 T‐cell responses following immune selection during HIV‐1 infection
NM Keane, SG Roberts, CAM Almeida, T Krishnan, A Chopra, E Demaine, ...
Immunology and cell biology 90 (2), 224-234, 2012
Applications of immunopharmacogenomics: predicting, preventing, and understanding immune-mediated adverse drug reactions
JH Karnes, MA Miller, KD White, KC Konvinse, RK Pavlos, AJ Redwood, ...
Annual review of pharmacology and toxicology 59, 463-486, 2019
Automation of the ELISpot assay for high-throughput detection of antigen-specific T-cell responses
CAM Almeida, SG Roberts, R Laird, E McKinnon, I Ahmed, K Pfafferott, ...
Journal of immunological methods 344 (1), 2009
Severe delayed drug reactions: role of genetics and viral infections
R Pavlos, KD White, C Wanjalla, SA Mallal, EJ Phillips
Immunology and Allergy Clinics 37 (4), 785-815, 2017
The system can't perform the operation now. Try again later.
Articles 1–20